Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wheatley

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
The Cochrane Database of Systematic Reviews|August 17, 2012
Physiotherapy versus placebo or no intervention in Parkinson's diseaseClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
The Cochrane Database of Systematic Reviews|July 13, 2012
Physiotherapy versus placebo or no intervention in Parkinson's diseaseClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
The Cochrane Database of Systematic Reviews|September 11, 2013
Physiotherapy versus placebo or no intervention in Parkinson's diseaseClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
The Cochrane Database of Systematic Reviews|June 18, 2014
Physiotherapy for Parkinson's disease: a comparison of techniquesClaire L Tomlinson, Clare P Herd, Carl E Clarke, et al.
The New England Journal of Medicine|November 13, 2009
Revascularization versus medical therapy for renal-artery stenosis, Keith Wheatley, Natalie Ives, et al.
Lancet (London, England)|December 15, 2022
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trialBernadette Brennan, Laura Kirton, Perrine Marec-Bérard, et al.
BMJ (Clinical Research Ed.)|July 24, 2019
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluationNicholas J A Webb, Rebecca L Woolley, Tosin Lambe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemiaAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Trials|June 9, 2014
Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trialCatherine M Sackley, Christina H Smith, Caroline Rick, et al.
Blood|June 14, 2005
RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 yearsDavid T Bowen, Marion E Frew, Robert Hills, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
The Cochrane Database of Systematic Reviews|August 17, 2012
Physiotherapy versus placebo or no intervention in Parkinson's diseaseClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
The Cochrane Database of Systematic Reviews|July 13, 2012
Physiotherapy versus placebo or no intervention in Parkinson's diseaseClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
The Cochrane Database of Systematic Reviews|September 11, 2013
Physiotherapy versus placebo or no intervention in Parkinson's diseaseClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
The Cochrane Database of Systematic Reviews|June 18, 2014
Physiotherapy for Parkinson's disease: a comparison of techniquesClaire L Tomlinson, Clare P Herd, Carl E Clarke, et al.
The New England Journal of Medicine|November 13, 2009
Revascularization versus medical therapy for renal-artery stenosis, Keith Wheatley, Natalie Ives, et al.
Lancet (London, England)|December 15, 2022
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trialBernadette Brennan, Laura Kirton, Perrine Marec-Bérard, et al.
BMJ (Clinical Research Ed.)|July 24, 2019
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluationNicholas J A Webb, Rebecca L Woolley, Tosin Lambe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemiaAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Trials|June 9, 2014
Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trialCatherine M Sackley, Christina H Smith, Caroline Rick, et al.
Blood|June 14, 2005
RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 yearsDavid T Bowen, Marion E Frew, Robert Hills, et al.
Pageof 15